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1. Introduction 
A severely ill neonate with cyanosis and respiratory distress is a diagnostic challenge. The 
clinician must perform a rapid evaluation to determine whether congenital heart disease is a 
cause so that potentially lifesaving measures can be instituted. 
2. Differential diagnosis 
The causes of cyanosis can be classified as respiratory, cardic, central nervous system ( CNS ) 
or other disorders. 
3. Evaluation 
During a physical examination if an infant appears blue, the following questions need 
immediate answer: 
3.1 Does the infant have respiratory distress?  
If the infant has increased respiratory effort with increased rate, retractions and nasal 
flaring, respiratory disease should be high on the list of differential diagnosis. Cyanotic 
heart disease usually presents without respiratory symptoms but can have effotless 
tachypnea ( rapid respiratory rate without retractions). 
3.2 Does the infant have murmor? 
A murmor usually implies heart disease. Transposition of great vessels can present without 
a murmor. 
3.3 Is the cyanosis continous, intermittent, sudden in oncet or occuring only with 
feeding? 
Intermittent cyanosis is more common with neurologic disorders, as these infants may have 
apneic spells alternating with periods of normal breathing. Continuous cyanosis is usually 
associated with intrinsic lung disease or heart disease. Cyanosis with feeding may occur 
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with esophageal atresia and severe esophageal reflux. Cyanosis that disappears with crying 
may signify choanal atresia. 
 
a. Respiratory diseases 
1. Lung diseases 
a. Hyaline membrane disease 
b. Transiet tachypnea of the newborn 
c. Pneumonia 
d. Meconium aspiration 
2. Air leak syndrome 
3. Congenital defects ( eg. Diaphragmatic hernia, hypoplastic lungs, lobar 
emphysema, cystic adenomatoid malformation, diaphragmal abnormality ) 
b. Cardiac diseases 
1. All cyanotic heart diseases includin transposition of great arteries, total 
anomalous pulmonary venous return, Ebstein's anomaly, tricuspid atresia, 
pulmonary atresia, pulmonary stenosis, tetralogy of Fallot, patent ductus 
arteriosus and ventricular septal defect 
2. Persistent pulmonary hypertension 
3. Severe congestive heart failure 
c. CNS diseases  
Periventricular-intraventricular hemorrhage, meningitis and primary seizure 
disorder can all cause cyanosis. Neuromuscular disorders such as Werdnong-
Hoffmanndisease and congenital myotonic dystrophy can cause cyanosis. 
d. Other disorders 
1. Methemoglobinemia 
2. Polycythemia/hyperviscostiy syndrome 
3. Hypothermia 
4. Hypoglycemia 
5. Sepsis 
6. Pseudocyanosis caused by fluorescent lighting 
7. Respiratory depression secondary to maternal medications ( eg. magnesium 
sulfate and narcotics ) 
8. Shock 
9. Upper airway obstruction. Choanal atresia is nasal passage obstruction caused 
most commonly by a bony abnormality. Other causes are laryngeal web, 
tracheal stenosis, goiter and Pierre Robin syndrome. 
Table 1. Differential diagnosis of cyanosis in the newborn 
3.4 Is there differential cyanosis? 
If there is cyanosis of upper or lower part of the body only, this usually signifies serious heart 
disease. The more common pattern is cyanosis restricted to the lower part of the body, which 
is seen in patients with patent ductus arteriosus with left-to right shunt. Cyanosis restricted to 
the upper half of the body is seen occasionally in patients with pulmonary hypertension, 
patent ductus arteriosus, coarctation of aorta and D-transposition of great arteries. 
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3.5 What is the prenatal and delivery history? 
An infant of a diabetic mother has increased risk of hypoglycemia, polycytemia, respiratory 
distress syndrome and heart disease. Infection, which can occur with premature rupture of 
membranes, may cause shock and hypotension with resultant cyanosis. Amniotic fluiod 
abnormalities, such as oligohydramnios ( associated with hypoplastic lungs ) or 
polyhydramnios ( associated with esophageal atresia ), may suggest a cause for cyanosis. 
Cesarean section is associated with increased respiratory distress. 
4. Cardiac disease 
Congenital heart disease produces cyanosis when obstruction to right ventricular outflow 
causes intracardiac right-to-left shunting or when complex anatomic defects, unassociated 
with pulmonary stenosis, cause an admixture of pulmonary and systemic venous return in 
the heart. Cynosis from pulmonary edema may also develop in patients with heart failure 
caused by left-to-right shunts, although the degree is usually less severe. Cyanosis may be 
caused by persistence of fetal pathways, for example, right-to-left shunting across the 
foramen ovale and ductus arterious in the presence of persistent pulmonary hypertension of 
the newborn (PPHN). 
5. Cardiac evaluation of newborn infant 
In the cardiac evaluation of the newborn infant, understanding the circulatory status at birth 
is very important. As the result of fetal circulation, newborn infants have right ventricular 
(RV) dominance associated with a thick RV wall, elevated pulmonary vascular resistance 
(PVR), and a thick medial layer of the pulmonary arterioles. The thick pulmonary artery 
smooth muscle gradually becomes thinner, and it resembles that of the adult by the time the 
baby is age 6 to 8 weeks. Most perinatal changes in hemodynamics are related to the 
thinning of the pulmonary vascular smooth muscle, resulting in a gradual fall in the PVR 
and a loss of RV dominance of the neonate. Premature infants in general have lessRV 
dominance than full-term infants, and the PVR is not as high in the full-term neonate, which 
adds variability to the process. Because of these unique aspects of the perinatal circulatory 
system, the basic tools in the initial cardiac evaluation discussed are less reliable and the 
findings may be different in the newborn infant. Therefore echo studies are commonly 
performed in the neonatal cardiac evaluation. Some important aspects of normal and 
abnormal findings in physical examination, electrocardiograpgy (ECG), and chest x-ray 
films of the neonate are briefly reviewed in this chapter.  
5.1 Physical examination 
1. Normal physical findings that are unique in normal newborn infants  
a. Heart rate is generally faster ( usually over 100 beats/min, with normal ranges 
from 70 to 180 beats/min) than that of older children and adults. 
b. A varying degree of acrocyanosis is the rule rather than the exception. 
c. Mild arterial desaturation with arterial Po2 as low as 60 mmHg is not unusual in an 
otherwise normal neonate. This may be caused by an intrapulmonary shunt 
through an as yet unexpanded portion of the lungs or by a right-to-left arterial 
shunt through the patent foramen ovale (PFO). 
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d. There is relative hyperactivity of the RV, with the point of maximal impuls (PMI)at 
the lower left sternal border (LLSB) rather than at the apex. 
e. The second heart sound (S2) may be single in the first days of life, and occasionally 
an ejection click (reflecting pulmonary hypertension) is audible. 
f. An innocent heart murmur may be present. The most common one in this age 
group is the pulmonary flow murmur of the newborn infant. 
g. Peripheral pulses are easily palpable in all extremities, including the foot, in every 
normal infant. 
2. Additional important features of premature infants 
a. The pulmonary flow murmur of the newborn infant is more frequent and louder in 
premature than in full-term infants.  
b. The likelihood of a patent ductus arteriosus (PDA) murmur is greater in premature 
infants. 
c. The peripheral pulses normally appear bounding because of the lack of a normal 
amount of subcutaneous tissue. 
3. Abnormal phycical findings 
The following abnormal physical findings cardiac pathology.  
a. Cyanosis, particularly when it does not improve with oxygen administration, 
requires further evaluation. 
b. Decreased or absent peripheral pulses in the lower extremities suggest coarctation 
of aorta (COA). Generalized weak peripheral pulses suggest hypoplastic left heart 
syndrome (HLHS) or circulatory shock. Bounding peripheral pulses suggest an 
aortic run-off lesion such as PDA or persistent truncus arterious. 
c. Tachypnea of greater than 60 breaths/min with or without retraction is abnormal. 
d. Hepatomegaly may suggest a heart defect manifesting with congestive heart failure 
(CHF). A midline liver suggests asplenia or polysplenia syndrome. 
e. A heart murmur may be a presenting sign of congenital heart disease (CHD). 
However, innocent murmurs are more common than pathologic murmurs.  
f. An irregular rhythm or abnormal heart rate may suggest cardiac arrhythmias. 
g. Blood pressure readings in the lower extremities 6 to 7 mm Hg lower than those in 
the arm require further evaluation for COA. 
5.2 Blood gases 
Normal 1-day-old infant may have P02 as low as 60 mmHg, but transcutaneous oxygen 
saturation is higher than 90%.  
5.3 Electrocardiographraphy 
1. The normal ECG of a newborn infant is different from that of a child or an adult as 
follows: 
a. Sinus tachycardia with a rate as high as 180 beats/min. 
b. A rightward QRS axis with a mean of +125 degrees and a maximum of +180 
degrees. 
c. Relatively small voltages for the QRS complex and the T wave. 
d. RV dominance with tall R waves in the RPLs (V4R, V1, and V2). 
e. Occasional q waves in V1(seen in about 10% of normal neonates) 
f. Benign arrhythmias 
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2. An abnormal ECG may be in the form of an abnormal P axis, abnormal QRS axis, 
hypertrophy of the ventricles or atria, vantricular conduction disturbances, or 
arrhythmias. Because of the wide ranges of normal values, many newborn infants with 
significant CHDs may show a normal ECG for their age. Arrhythmias in neonates are 
discussed later in this chapter. 
a. P axis 
1. A P axis in the right lower quadrant ( +90 to + 180 degrees) suggests atrial situs 
inversus, asplenia syndrome, or incorrectly placed ECG electrodes. 
2. A superor P axis suggests an ectopic atrial rhythm, as seen in polysplenia 
syndrome. 
b. QRS axis 
1. A superiorly oriented QRS axis between 0 and -150 degrees ( left anterior 
hemiblock) suggests partial or complete ECD, including splenic syndromes, or 
tricuspid atresia. 
2. A QRS axis less than + 30 degrees is abnormal and indicates left axis deviation 
(LAD) in the neonate. The QRSetween + 30 and +60 degrees is unusual and 
indicates relative LAD. 
3. A QRS axis greater than +180 degrees (in the range of -150 to -180 degrees) 
may indicate RAD. 
c. Left ventricular hypertrophy (LVH) is suggested in the newborn infant when the 
following are present: 
1. Left atrial hypertrophy (LAD) or relative LAD (less than +60 degrees) for the 
neonate. 
2. An R/S progression in the precordial leads that resembles the adult R/S 
progression. 
3. QRS voltages demonstrating abnormal leftward and posterior forces or 
abnormal inferior forces for age 
d. Right ventricular hypertrophy (RVH) is difficult to diagnose because of the normal 
dominance of the RV at this age. However, the following are helpful clues to RVH 
in the newborn infant. 
1. S waves in lead I 12 mm or greater 
2. Pure R waves with no S waves in V1 greater than 10 mm. 
3. R waves in V1 greater than 25 mm or R waves in aVR greater than 8 mm. 
4. A qR pattern in V1 ( this is also seen in 10% of normal neonates). 
5. Upright T waves in V1 after 3 days of age. 
6. Right axis deviation (RAD) with the QRS axis greater than + 180 degrees. 
e. Atrial hypertrophy 
1. Right atrial hypertrophy (RAH) is present when the P wave amplitude is 
greater than 3 mm in any lead. 
2. Left atrial hypertrophy (LAH) iswhen the P wave duration is 0.08 sec or 
greater (usually with notched P waves in the limb leads and biphasic P waves 
in V1). 
f. Ventricular conduction disturbances ( i.e , right bundle branch block (RBBB),left 
bundle branch block (LBBB), Wolff-Parkinson-Wite (WPW) syndrome, and 
intraventricular block)are present when the QRS duration is 0.07 sec or more ( not 
0.1 sec or greater as in the adult) 
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1. RBBB may be associated with Ebstein anomaly and COA in the newborn. It is 
sometimes seen in otherwise normal neonates. 
2. LBBB is extremely rare in the newborn infant. 
3. Intraventricular block ( with a widening of the QRS complex throughout the 
QRS duration) is more significant than RBBB because it is often associated with 
significant metabolic abnormalities (e.g., hypoxia, acidosis, hyperkalemia) and 
diffuse myocardial diseases. 
4. WPW syndrome may be an isolated finding or may be associated with CHDs 
such as Ebstein anomaly or L-TGA. It is a frequent cause of SVT. 
5.4 Chest roentgenography 
1. Normal CXR findings 
a. The cardiothoracic (CT) ratio of normal newborn infants may be greater than 0.5 
because of inadequate inspiration and a large thymic shadow. 
b. The thymic shadow may have any of several shapes, including a classic sail sign, or 
may have undulant or smooth borders, either unilateral or bilateral, on the upper 
mediastinum. 
c. Cardiac silhouette is not always as well defined in neonates as in older children. 
d. Evaluation of pulmonary vascular markings in the neonate poses a special 
problem. Although a reduced PBF is usually easier to detect ( and indicates serious 
cyanotic CHD), increased vascularity is not always apparent even when the 
pulmonary blood flow is large. The distinction between increased PBF and 
pulmonary venous congestion is often difficult. 
2. Abnormal chest x-ray findings: A cardiac problem is suggested by an abnormal size, 
position, or silhouette of the heart, by an abnormal shape or position of the liver, and by 
increased or decreased pulmonary vascularity on CXR films. 
a. Heart size 
The CT ratio is of limited value, since that of normal neonates is usually greater 
than 0.5. Many serious CHDs that eventually result in cardiomegaly show a normal 
heart size in neonates. Unequivocal cardiomegaly may be due to CHD (such as 
ventricular septal defect (VSD), PDA, transposition of the great arteries (TGA), 
Ebstein anomaly, hypoplastic left heart syndrome (HLHS), and other), myocarditis 
or cardiomyopathy, pericardial effusion, metabolic disturbance (e.g., 
hypoglycemia, severe hypoxemia, and acidosis), and overhydration or 
overtransfusion. 
In the newborn infant who is intubated and on a ventilator, the heart size is greatly 
influenced by the ventilator setting. For example, a premature infant with a large-shunt 
PDA may have a normal-sized heart on chest x-ray film if the ventilator settings are 
high, especially the positive end-expiratory pressure. 
b. Abnormal cardiac silhouettes may be of considerable help in suggesting the correct 
diagnosis. 
1. A boot-shaped heart (coeur en sabot) is seen in tetralogy of Fallot (TOF) and in 
tricuspid atresia. 
2. An egg-shaped heart with narrow waist may be seen in TGA. 
3. A large, globular heart is seen in Ebstein anomaly. 
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c. Dextrocardia or mesocardia 
The presence of dextrocardia or mesocardia does not always indicate a serious 
heart defect. The segmental approach should be used for further evaluation. Four 
common situations seen in dextrocardia or mesocardia are situs inversus totalis 
with a normal heart, a rightward displacement of a normallyformed heart due to 
hypoplasia of the right lung, a complex cyanotic CHD, and asplenia or polysplenia 
syndrome. 
d. The situs of abdominal viscera: A left-sided liver with the heart in the right side of 
the chest is seen in situs inversus totalis with normal heart. The liver and the 
cardiac apex on the same side suggest a complex cyanotic CHD. A midline liver 
suggests asplenia or polysplenia syndrome. 
e. Pulmonary vascular markings 
1. Increased pulmonary vascular marking (PVM) in a cyanotic infant suggest 
TGA, persistent truncus arteriosus, or single ventricle. In an acyanotic infant, 
increased PVMs suggest VSD, PDA, or endocardial cushion defect (ECD). 
2. Decreased PVMs suggest a critical cyanotic CHD with decreased pulmonary 
blood flow(PBF), such as pulmonary atresia, tricuspid atresia, mor TOF with 
severe pulmonary stenosis or atresia. 
3. A ground-glass appearance or a reticulated pattern of the lung fields is 
characteristic of pulmonary venous obstruction. 
6. Suggested approach to neonates with central cyanosis 
a. Although a significant heart murmur usually suggests a cardiac basis for the cyanosis, 
several of the more severe cardiac defects (transposition of the great vessels) may not 
initially be associated with a murmur.  
Heart murmurs.  
1. Innocent heart murmurs: More than 50% of full-term newborn infants ( and a 
higher percentage of premature infants) have an innocent systolic murmur at some 
time during the first week of life. Infants with innocent heart murmurs have 
normal ECG and chest x-ray findings. The four most common innocent murmurs in 
the newborn period are as follows: 
a. Pulmonary flow murmur is most common. It is more often found in premature 
and small-for-gestational-age infants than in full-term infants. A soft systolic 
murmur ( grade 1 to 2/6), heard best at the upper left sternal border (ULSB), 
transmits well to bozh sides of the chest, axillae, and the back. 
b. Transient systolic murmur of PDA is soft ( grade 1 to 2/6), audible at the ULSB 
and in the left infraclavicular area on the first day. It usually disappears 
shortly thereafter. 
c. Transient systolic murmur of tricuspid regurgitation is indistinguishable from 
that of VSD and is most common in infants who had fetal distress or neonatal 
asphyxia. 
d. Vibratory systolic innocent murmur is a counterpart of Still's murmur in older 
children. It is audible at the LLSB, apex, or midprecordium. 
2. Pathologic heart murmurs: Most pathologic murmurs except atrial septal defect 
(ASD) are audible during the first month of life. The time of appearance of a 
murmur depends on the nature of the defect. 
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a. Heart murmurs of stenotic lesions (e.g., aortal stenosis (AS), pulmonary 
stenosis (PS)) are audible immediately after birth and persist, because they are 
independent of the level of the PVR. 
b. Heart murmurs of L-R shunt lesions, especially those of a large VSD, may 
appear later, when the PVR decreases. The murmur of ASD appears late in 
infancy or in childhood. 
c. The continuous murmur of a large PDA may not appear for 2 to 3 weeks. 
Instead, it is a crescendo systolic murmur with a slight or no diastolic 
component. 
Even in the absence of a murmur, a newborn infant may have a serious heart defect 
that requires immediate attention, e.g., severe cyanotic heart disease such as TGA 
or pulmonary atresia with a closing PDA. Infants who are in severe CHF may not 
have a loud murmur until the myocardial function is improved with anticongestive 
measures.  
b. Chest x-ray films may reveal pulmonary causes of cyanosis and urgency of the 
problem.They will also hint at the presence and the type of any cardiac defects. 
c. Arterial blood gases on room air will confirm or rule out central cyanosis. Elevated Pco2 
suggests pulmonary or central nervous system (CNS) problems. Low pH may be seen 
in sepsis, circulatory shock, or severe hypoxemia. 
d. Hyperoxia test is one method of distinguishing cyanotic congenital heart disease from 
pulmonary disease. Neonates with cyanotic congenital heart disease usually do not 
have significantly raised arterial Pao2 during administration of 100% oxygen. If the 
Pao2 rises above 150 mmHg during 100% oxygen administration, an intracardiac shunt 
can usually be excluded, although the Pao2 of some patients with cyanotic congenital 
heart lesions may be transiently increased to greater than 150 mm Hg because of 
intracardiac streaming patterns. The Pao2 in patiens with pulmonary disease generally 
increases significantly as ventilation – perfusion inequalities are overcome by oxygen 
administration. In infants with a CNS disorder, the Pao2 completely normalizes during 
artificial ventilation. Hypoxia in many heart lesions is profound and constant, whereas 
in respiratory disorders and in primary hypertension of the neonate (PPHN), arterial 
oxygen tension is not as low and often varies with time or changes in ventilator 
management. Hyperventilation may improve the hypoxia in neonates with PPHN and 
only occasionally in those with cyanotic heart disease. 
e. An ECG should be obtained if a cardiac origin of cyanosis is suspected. 
f. Two-dimensional echocardiography is the definitive noninvasive test to determine the 
presence of congenital heart disease. The information obtained is essential in avoiding 
unnecessary cardiac catheterization and angiography in the absence of a cardiac defect, 
as well as in making a specific diagnosis.  
g. Umbilical artery line: A Po2 value in a preductal artery ( such as right radial artery) 
higher than that in a postductal artery (umbilical artery line) by 10 to 15 mm Hg 
suggests an R-L shunt through a PDA. Such a differential Po2 level may result from 
persistent pulmonary hypertension of the newborn (PPHN), critical AS, interrupted 
aortic arch, or coarctation of the aorta. An echo study will clarify the cause of the 
differential Po2 levels. 
h. Cardiology consultation is called for if a cardiac origin of cyanosis is suspected. 
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7. Heart failure in the newborn infant 
The clinical picture of CHF in the neonate may simulate another disorder such as meningitis, 
sepsis, pneumonia, or bronchiolitis. Tachypnea, tachycardia, pulmonary crackles or rhonchi, 
hepatomegaly, and weak peripheral pulses are common presenting signs. Heart murmur is 
either faint or absent. Cardiomegaly on chest x-ray film is always present, with or without 
increased PVMs or pulmonary edema. Causes of CHF in the neonate are listed in Table 2. 
 
a. Structural heart defects 
At birth 
Hypoplastic left heart syndrome (HLHS) 
Severe tricuspid or pulmonary regurgitation 
Large systemic AV fistula 
Week 1 
TGA 
Large PDA in premature infant 
Total anomalous pulmonary venous return (TAPVR) below diaphragm 
Week 1-4 
Critical AS or PS 
Preductal COA 
b. Noncardiac causes 
1. Birth asphyxia (resulting in transient myocardial ischemia) 
2. Metabolic: hypoglycemia, hypocalcemia 
3. Severe anemia (as seen in hydrops fetalis) 
4. Neonatal sepsis 
5. Overtransfusion or overhydration 
c. Myocardial disease 
1. Myocarditis 
2. Transient myocardial ischemia ( with or without birth asphyxia) 
3. Catdiomyopathy ( seen in infants of diabetic mothers) 
d. Disturbances in heart rate 
1. Supravetricular tachycardia (supraventricular tachycardia (SVT) or 
paroxysmal atrial tachycardia(PAT)) 
2. Atrial flutter or fibrillation 
3. Congenital heart block ( when associated with CHD) 
The time of onset of CHF varies rather predictably with the type of CHD.  
Table 2. Cause of heart failure in the neonate 
Two important CHDs that present with CHF in the newborn period are hypoplastic left 
heart syndrome (HLHS) and large PDA in premature infants. Transient myocardial 
ischemia and infants of diabetic mothers are other causes of CHF in the neonate.  
8. Hypoplastic left heart syndrome 
a. Prevalence:HLHS occurs in 1% of all CHDs and is the most common cause of death 
from CHD during the first month of life. 
b. Pathology and pathophysiology 
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1. HLHS includes a group of closely related anomalies characterized by hypoplasia of 
the left ventricul (LV) ( from atresia or severe stenosis of the aortic and/or mitral 
valves) and hypoplasia of the ascending aorta and aortic arch. The LA is small, and 
the atrial septum is frequently intact other than the PFO. 
2. During fetal life the pulmonary vascular resistance (PVR) is higher than the 
systemic vascular resistance (SVR), and the dominant RV maintains normal 
perfusing pressure in the descending aorta through the ductal R-L shunt, even in 
the presence of the nonfunctioning hypoplastic LV. However, difficulties arise after 
birth, primarily from two factors: (1) reversal of the vascular resistance in the two 
circuits with the SVR higher than the PVR, and (2) closure of the PDA. The end 
result is a marked decrease in systemic cardiac output and aortic pressure, 
resulting in circulatory shock and metabolic acidosis. An increase in PBF in the 
presence of the nonfunctioning LV results in an elevated LA pressure and 
pulmonary edema. 
c. Clinical manifestations 
1. The neonate is critically ill in the first few hourse to days of life, with mild cyanosis, 
tachycardia, tachypnea, and pulmonary crackles. 
2. Poor peripheral pulses and vasoconstricted extremities are characteristic. The S2 is 
loud and single. Heart murmur is usually absent, but a grade 1 to 3/6 ejection 
systolic murmur may be present over the precordium. 
3. The ECG shows RVH. Rarely, left ventricular hypertrophy (LVH) pattern is present 
because V5 and V6 electrodes are placed over the dilated RV. 
4. Chest x-ray films show pulmonary venous congestion or pulmonary edema. The 
heart is only mildly enlarged. 
5. The arterial blood gas determination reveals severe metabolic acidosis in the 
presence of a slightly decreased Po2, a characteristic finding of this condition. 
6. Echo findings are diagnosticand usually obviate cardiac catheterization. Severe 
hypoplasia of the aorta and aortic annulus and the absent or distorted mitral valve 
are usually imaged. The LV cavity is diminutive. The RV cavity is markedly 
dilated, and the tricuspid valve is large.A partially constricted PDA may be 
imaged. 
7. Progressive hypoxemia and acidosis result in death, usually in the first month of 
life. 
d. Management 
1. Preoperatively the goal is to achieve adequate systemic oxygen delivery. Patency of 
the ductus arteriosus is critical for survival until surgery. Blood flow to the 
pulmonary and systemic circulations should be nearly balanced (goal p/s ratio of 
1). The immediate therapy for all infants with HLHS is an intravenous infusion of 
prostaglandin E1 (PGE1) in order to pharmacologically manipulate the ductus 
arteriosus (DA) and maintain ductal patency. A continuous infusion of the 
prostaglandin is initiated, preferably through a central catheter, at a rate of 0.05 to 
0.1 µg/kg per minute. However, numerous side effects are associated with PGE1 
infusion such as respiratory depression, fever, lethargy, irritability, myoclonic jerks, 
flushing, edema, pyloric stenosis, hyperostosis, necrotizing enetrocolitis, as well as 
structural remodeling of the DA and the pulmonary vessels, with a reported 
incidence of these complications ranging from 10 to 40%. (7,8) In the future 
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Sildenafil could be a reasonable alternative to PGE1 for maintaining DA patency, 
since it can also prevent and reverse DA closure through a mechanism that is 
distinct, and eventually safer, from the PGE1 mechanism. (9) An audible murmur 
and adequate peripheral perfusion provide evidence of ductal patency; however, 
Doppler echocardiography is needed to confirm flow. Once the ductus is open, the 
rate of infusion may be reduced to decrease the risk for potential adverse effects. 
Unrestricted blood flow through the ductus arteriosus is necessary for systemic 
perfusion. Sometimes even a temporary discontinuation of the prostaglandin 
infusion is possible, with careful monitoring of blood pressure and urine volume as 
well as frequent echocardiographic examinations, in order to enable maintenance 
of balance between systemic and pulmonary blood flow. (4) 
The pulmonary/systemic (p/s) ratio preoperatively is dictated by the adequacy of 
the interatrial communication. An infant with a mildly restrictive interatrial 
communication may have balanced circulation and remain in a clinically stable 
condition as long as the ductus arteriosus remains open. Oxygen saturations of 75% 
to 85% by pulse oximetry suggest adequate balance between systemic and 
pulmonary blood flow. Ventilatory support may be needed for apneic episodes or 
tenacious secretions, both common adverse effects of treatment with prostaglandin 
E1. Judicious use of inotropic support is initiated if evidence of low cardiac output 
is detected. Infusion of dopamine at a rate of 3 to 5 µg/kg per minute usually 
results in improved ventricular function. High-dose inotropic support should be 
used with caution because it can result in increased SVR and cause a shift in the 
p/s ratio to greater than 1. In our institution we do not recommend the use of 
dopamine as a “standard” since we consider it a “dirty” drug with a lot of potential 
unexpected effects. Diuretics may be necessary to help alleviate the increased 
volume load on the right ventricle. 
Infants with an unrestrictive inter-atrial communication may be in a stable 
condition initially, but signs of congestive heart failure may develop as the PVR 
(pulmonary vascular resistance) decreases. When oxygen saturations are 
approximately 90%, systemic blood flow may be reduced, resulting in tissue 
hypoperfusion, metabolic acidosis, and a low cardiac output state. In infants with 
high oxygen saturation and evidence of tissue hypoperfusion, controlled 
mechanical ventilation is often initiated to improve the p/s ratio and systemic 
cardiac output. 
Severe tricuspid regurgitation (TR) could be another issue that complicates the life 
of the intensivist dealing with a newborn with HLHS. Good preoperative 
management with mechanical ventilation in order to lower the degree of TR results 
in a better short-term prognosis of stage 1 Norwood operation. (4) 
The goal of respiratory management is to increase pulmonary vascular resistance 
and decrease systemic vascular resistance. The p/s ratio can be manipulated by 
increasing PVR by increasing the PaCO2. PaCO2 can be increased by adding 
supplemental inspired carbon dioxide, a potent pulmonary vasoconstrictor, to the 
ventilator circuit. This approach for increasing PaCO2 is preferred over 
hypoventilation, which may lead to atelectasis. PVR can also be increased by 
decreasing the concentration of inspired oxygen by adding supplemental nitrogen 
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gas to attain a fraction of inspired oxygen of 0.17 to 0.19. PVR can also be increased 
by maintaining the hematocrit at greater than 0.40, a state that optimizes oxygen-
carrying capacity and increases the viscosity of the blood. Although these medical 
management strategies may provide temporary palliation, infants with marked 
pulmonary overcirculation and systemic hypoperfusion benefit from early surgical 
correction, because the methods to reverse this situation have limited effectiveness. 
Infants with HLHS who are born with a severely restricted or no inter-atrial 
communication, a rare occurrence, have profound hypoxemia. In fact, morbidity 
and mortality remain high in the subset of patients with an intact or very restrictive 
atrial septum. (10) The severe restriction of blood flow across the atrial septum 
results in a life-threatening situation and these patients, which present with severe 
cyanosis and hemodynamic instability, require urgent postnatal cardiac 
catheterization to relieve the septal obstruction and improve oxygenation. (11) 
Relief of the obstruction can be achieved by a balloon atrial septostomy or blade 
septostomy at the time of cardiac catheterization or a surgical atrial septectomy. 
The tenuous condition of these infants makes each of these interventions high risk. 
The choice of intervention depends on the severity of the obstruction, the infant’s 
cardiac anatomy and physiology, and the experience of the available medical and 
surgical team. 
2. Surgical: Three options are available in the management of these infants:do nothing 
or choose one of two surgical options. The surgical options are the Norwood 
operation (followed by a Fontan operation) and cardiac transplantation. The 
surgical procedure of choice remains controversial. 
1. Norwood operation 
a. The first-stage Norwood operation is performed on the neonate. This 
operation consists of (1) division of the MPA and closure of the distal 
stump, (2) a right-sided Gore-Tex shunt (usually a 4-mm tube) to provide 
PBF, (3) excision of the atrial septum ( for adequate interatrial mixing), 
and (4) construction of a new aortic arch between the proximal main 
pulmonary artery (MPA) and the hypoplastic ascending aorta and aortic 
archm using an aortic or pulmonary artery allograft. The surgical 
mortality rate is 35% or higher.  
b. A cavopulmonary shunt ( or bidirectional Glenn operation) is carried out 
at 6 months of age. Mortality is less than 5%. 
c. A modified Fontan operation is carried out when the patient is a year and 
a half old. Overall survival after the Fontan operation is about 50% at 4 
years. 
2. Cardiac transplantation is considered to be the procedure of choice in some 
centers. The transplantation is not a cure for the defect but creates a lifelong 
medical problem, the threat of infection and rejection. 
9. Premature neonates with a large PDA 
a. Prevalence. 
Significant PDA with CHF occurs in 15% of prematures with a birth weight of less than 
1,750 g and in 40% to 50% of those with a birth weight of less than 1,500 g. 
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b. Pathophysiology 
This is a special problem in premature infants who have been recovering from hyaline 
membrane disease. With improvement in oxygenation the PVR drops rapidly, but the 
ductus remains patent because its responsiveness to oxygen is immature in the 
premature newborn infant. The resulting large L-R ductal shunt makes the lungs stiff, 
and weaning the infant from ventilator and oxygen therapy becomes difficult. Infants 
who remain on ventilators for a long time develop bronchopulmonary dysplasia with 
resulting pulmonary hypertension ( cor pulmonale) and right-sided heart failure. 
c. Clinical manifestations 
1. The history usually reveals that a premature infant with hyaline membrane disease 
has made some improvement during the first few days after birth, but this is 
followed by inability to wean the infant from the ventilator or a need to increase 
ventilator settings or oxygen requirement in 4-to 7-day-old premature infants. 
Apneic spells or episodes of bradycardia may be initial signs in infants who are not 
on ventilators. 
2. Bounding peripheral pulses and a hyperactive precordium are usually present. The 
classic continuous murmur of PDA at the ULSB is diagnostic, but the murmur is 
sometimes systolic only at the middle and upper LSB. Premature infants who are 
fluid overloaded or retaining fluid may also present with the hyperdynamic 
precordium, an ejection systolic murmur, bounding pulse, and wide pulse 
pressure. 
3. The ECG is usually normal. 
4. Chest x-ray films show cardiomegaly and evidence of pulmonary edema or 
pulmonary venous congestion in addition to varying degrees of the lung disease. 
5. 2D echo study confirms the diagnosis. It provides anatomic information about the 
diameter, length, and shape of the ductus. The Doppler study of the ductus ( with 
the sample volume placed at the pulmonary end of the ductus) provides important 
functional information such as ductal shunt patterns ( pure L-R, bidirectional, or 
predominant R-L shunt), pressure in the PA, and magnitude of the ductal shunt or 
pulmonary perfusion status. An indirect estimate of the magnitude of the shunt can 
be made by the LA and LV dimensions. 
d. Management: For symptomatic infants, either pharmacologic ( indomethacin) or 
surgical closure of the ductus is indicates. A small PDA that is not causing CHF should 
be followed up medically for 6 months without surgical ligation because of the 
possibility of spontaneous closure. 
1. Indomethacin ( a prostaglandin synthetase inhibitor), 0.2 mg/kg IV every 12 hours 
for up to three doses, may be used on selected cases. A second course is 
occasionally necessary for adequate ductal closure. Contraindications to the use of 
indomethacin include (1) BUN over 25 mg/dL or creatinine levels over 1.8 mg/dL, 
(2) a platelet count below 80,000/mm³, (3) a bleeding tendency ( including 
intracranial hemorrhage), (4) necrotizing enterocolitis, and (5) hyperbilirubinemia. 
2. A European study showed that ibuprofen given IV ( 10 mg/kg followed by 5 
mg/kg every 24 hours, two times), starting on the 3rd day of life, was as effective 
as indomethacin ( 0.2 mg/kg IV every 12 hours, three times), with a lower 
incidence of oliguria and a less deleterious effect on the cerebral blood flow than 
indomethacin. However, ibuprofen is not approved for use in premature PDA in 
this country. 
www.intechopen.com
 
Congenital Heart Disease – Selected Aspects 
 
246 
3. If the medical treatment is unsuccessful or if the use of indomethacin is 
contraindicated, a surgical ligation of the ductus is indicated. The standard 
operative approach to the PDA has been through a posterolateral thoracotomy. 
The safety, effectiveness, and minimally invasive nature of video-assisted 
thoracoscopic surgery (VATS) have been reported for premature PDA. 
Advantages of the technique may include no need to cut the muscle and to 
spread ribs, thus a reduced compromise of respiratory mechanics and of chest 
wall deformity. 
10. Persistent pulmonary hypertension of the newborn 
(Persistent Fetal Circulation) 
PPHN occurs in term and post-term infants. Predisposing factors include birth asphyxia, 
meconium aspiration pneumonia, early-onset sepsis, hypoglycemia, polycythemia, maternal 
use of nonsteroidal anti-inflammatory drugs with in utero constriction of the ductus 
arterious, and pulmonary hypoplasia as a result of diaphragmatic hernia, amniotic fluid 
leak, oligohydramnions, or pleural effusions. PPHN is often idiopathic. Some patients with 
PPHN have low plasma arginine and nitric oxide metabolite concentrationsand 
polymorphisms of the carbamoyl phosphate synthase gene, findings suggestive of a possible 
subtle defect in nitric oxide production. The incidence is 1/500-1,500 live births with a wide 
variation between different clinical centers. 
a. Pathophysiology: Persistence of the fetal circulatory pattern of right-to-left shunting 
through the PDA and foramen ovale after birth is due to excessively high pulmonary 
vascular resistance. Fetal pulmonary vascular resistance is usually elevated relative to 
fetal systemic or postnatal pulmonary pressure. This fetal state permits shunting of 
oxygenated umbilical venous blood to the left atrium ( and brain) through the foramen 
ovale and bypasses the lungs through the ductus arterious to the descending aorta. 
After birth, pulmonary vascular resistance normally declines rapidly as a consequence 
of vasodilation secondary to gas filling the lungs, a rise in postnatal Pao2, a reduction in 
Pco2, increased pH, and release of vasoactive substances. Increased neonatal 
pulmonary vascular resistance may (1) be maladaptive from an acute injury (e.g., not 
demonstrating normal vasodilation in response to increased oxygen and other changes 
after birth); (2) be the result of increased pulmonary artery medial muscle thickness and 
extension of smooth muscle layers into the usually nonmuscular, more peripheral 
pulmonary arterioles in response to chronic fetal hypoxia; (3) be due to pulmonary 
hypoplasia ( diaphragmatic hernia, Potter syndrome); (4) be obstructive as a result of 
polycythemia or total anomalous pulmonary venous return; or (5) be due to alveolar 
capillary dysplasia, a lethal, possibly familial disorder characterized by a thickened 
alveolar septum and a reduced number of small pulmonary arteries and capillaries. 
Apart from the etiology, profound hypoxia from right-to-left shunting and normal or 
elevated Pco2 are present. 
b. Clinical Manifestations: Infants become ill in the delivery room or within the first 12 hr 
of life. PPHN related to polycythemia, idiopathic causes, hypoglycemia, or asphyxia 
may result in severe cyanosis with tachypnea, although initially, signs of respiratory 
distress may be minimal. Infants who have PPHN associated with meconium 
aspiration, group B streptococcal pneumonia, diagphragmatic hernia, or pulmonary 
hypoplasia usually exhibit cyanosis, grunting, flaring, retractions, tachycardia, and 
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shock. Multiorgan involvement may be present. Myocardial ischemia, papillary muscle 
dysfunction with mitral and tricuspid regurgitation, and cardiac stunning produce 
cardiogenic shock with decreased pulmonary blood flow, tissue perfusion, and oxygen 
delivery. The hypoxia is quite labile and often out of proportion to the findings on chest 
roentgenograms. 
c. Diagnosis: PPHN should be suspected in all term infants who have cyanosis with or 
without fetal distress, intrauterine growth restriction, meconium-stained amniotic fluid, 
hypoglycemia, polycythemia, diaphragmatic hernia, pleural effusions, and birth 
asphyxia. Hypoxia is universal and is unresponsive to 100% oxygen given by oxygen 
hood, but it may respond transiently to hyperoxic hyperventilation administered after 
endotracheal intubation or to the application of a bag and mask. A Pao2 gradient 
between a preductal (right radial artery) and a postductal (umbilical artery) site of 
blood sampling greater than 20 mm Hg suggest right-to-left shunting through the 
ductus arteriosus. Real-time echocardiography combined with Doppler flow studies 
demonstrates right-to-left shunting across a patent foramen ovale and a ductus 
arteriosus. Deviation of the intraatrial septum into the left atrium is seen in severe 
PPHN. Tricuspid or mitral insufficiency may be noted on auscultation as a holosystolic 
murmur and can be visualized echocardiographically together with poor contractility 
when PPHN is associated with myocardial ischemia. The degree of tricuspid 
regurgitation can be used to estime pulmonary artery pressure. The 2nd heart sound is 
accentuated and not split. In asphyxia-associated and idiopathic PPHN , the chest 
roentgenogram is normal, whereas in PPHN associated with pneumonia and 
diaphragmatic hernia, it shows the specific lesions of parenchymal opacification and 
bowel in the chest, respectively. The differential diagnosis of PPHN includes cyanotic 
heart disease (especially obstructed total anomalous pulmonary venous return) and the 
associated etiologic entities that predispose to PPHN (e.g., hypoglycemia, 
polycythemia, sepsis). 
d. Treatment: Therapy is directed toward correcting any predisposing disease ( 
hypoglycemia, polycithemia) and improving poor tissue oxygenation. The response to 
therapy is often unpredictable, transient, and complicated by the adverse effects of 
drugs or mechanical ventilation. Initial management includes oxygen administration 
and correction of acidosis, hypotension, and hypercapnia. Persistent hypoxia should be 
managed with intubation and mechanical ventilation.  
Treatment with inhaled nitric oxide (iNO) is indicated for newborns with an oxygen 
index (OI) of less than 25. Nitric oxide (NO) is an endothelially derived gas signaling 
molecule that relaxes vascular smooth muscle and that can be delivered to the lung 
by means of an inhalation device . In 2 large, randomized trials, NO reduced the need 
for extracorporeal membrane oxygenation (ECMO) by approximately 40%. Although 
these trials led to the US Food and Drug Administration (FDA) approving iNO as a 
therapy for persistent pulmonary hypertension of the newborn (PPHN), iNO did not 
reduce mortality, the length of hospitalization, or the risk of neurodevelopmental 
impairment. A randomized study confirmed that beginning iNO at a milder or earlier 
point in the disease course (for an oxygenation index of 15-25) did not decrease the 
incidence of ECMO and/or death or improve other patient outcomes, including the 
incidence of neurodevelopmental impairment.The use of iNO has not been 
demonstrated to reduce the need for ECMO in newborns with congenital 
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diaphragmatic hernia. In these newborns, iNO should be used in non-ECMO centers 
to allow for acute stabilization, followed by immediate transfer to a center that can 
provide extracorporeal membrane oxygenation (ECMO).Contraindications to iNO 
include congenital heart disease characterized by left ventricular outflow tract 
obstruction (eg, interrupted aortic arch, critical aortic stenosis, hypoplastic left heart 
syndrome) and severe left ventricular dysfunction.The appropriate starting dose is 20 
ppm. Doses higher than this have not been shown to be more effective and have been 
associated with adverse effects, including methemoglobinemia and increased levels 
of nitrogen dioxide (NO2).Appropriate lung recruitment and expansion are essential 
to achieve the best response. If a newborn has severe parenchymal lung disease and 
PPHN, strategies such as HFV may be required.Most newborns require iNO for less 
than 5 days. In general, the dose can be weaned to 5 ppm after 6-24 hours of therapy. 
The dose is then slowly weaned and discontinued when the FiO2 is less than 0.4-0.6 
and the iNO dose is 1 ppm. Abrupt discontinuation at higher doses should be 
avoided because it may cause abrupt rebound pulmonary hypertension. In centers 
that do not have immediate availability of ECMO support, use of iNO must be 
approached with caution. Because iNO cannot be abruptly discontinued, transport 
with iNO is usually needed if a subsequent referral for ECMO is necessary. This 
capability should be determined in collaboration with the ECMO center before 
treatment is started. The use of iNO with high frequency ventilation (HFV) creates 
particular problems for transport, and this should be considered before these 
therapies are combined in a non-ECMO center. 
ECMO, an adaptation of cardiopulmonary bypass, is used when optimal support fails 
to maintain acceptable oxygenation and perfusion . The introduction of ECMO and 
other new therapies has had a major effect on reducing the mortality rate associated 
with PPHN. ECMO support can now be provided using a double-lumen catheter in the 
internal jugular vein; thus, ligation of the right common carotid artery can be avoided. 
Although iNO is an effective pulmonary vasodilator, ECMO remains the only therapy 
that has been proven to be life-saving for PPHN. Therefore, timely transfer to an ECMO 
center is vital for newborns with severe PPHN.However, it is often difficult to 
determine the proper timing of a referral to an ECMO center. Referral and transfer 
should occur before refractory hypoxemia develops. Early consultation and discussion 
with clinicians at the ECMO center is strongly recommended. Continuous delivery of 
NO is required during transport. Baseline criteria for newborns considered for ECMO 
are generally as follows: 
 Gestation of more than 34 week 
 Weight more than 2000 g 
 No major intracranial hemorrhage on cranial sonograms (ie, larger than a grade II 
hemorrhage) 
 Reversible lung disease or mechanical ventilation for 7-14 days 
 No evidence of lethal congenital anomalies or inoperable cardiac disease 
11. Transient myocardial ischemia 
a. Prevalence 
Transient myocardial ischemia is a rarely recognized condition; the prevalence is 
unknown. 
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b. Pathology and pathophysiology 
1. Subendocardial ischemia or necrosis ( possibly secondary to hypoxic pulmonary 
vasoconstriction) occurs in the papillary muscles and other areas of the ventricles 
in the newborn infant who had prenatal or perinatal hypoxia and distress. 
Evidence of pulmonary hypertension, bidirectional shunts at the atrial and/or 
ductal levels, and TR are usually present. Variable degrees of LV dysfunction are 
demonstrable by echocardiography. 
2. Three levels of severity have been recognized. 
a. Transient tachypnea of the newborn is the mildest form of the condition. Mild 
LV dysfunction leads to fluid retention, pulmonary edema, and reduced lung 
compliance producing tachypnea. 
b. Transient tricuspid ( or mitral) regurgitation results from papillary muscle 
infarction ( evidenced by elevated serum levels of creatine phosphokinase MB 
fraction). 
c. Severe CHF with cardiogenic shock is the most severe form of myocardial 
dysfunction seen in the newborn infant. 
c. Clinical manifestations 
1. Tachypnea develops usually in full-term neonates with a low Apgar score. Mild 
cyanosis may also be present. 
2. A systolic murmur of TR or MR is commonly present. Rarely, CHF with gallop 
rhythm, hypotension, and vascular collapse result. 
3. The ECG may show generalized flat T waves and minor ST segment depression. 
Abnormal Q waves suggestive of anterior or inferior infarction may be seen. 
4. CXR films show varying degrees, sometimes marked, of cardiomegaly. PVMs may 
be increased due to pulmonary venous congestion ( described as wet lung) in 
severely affected neonates. 
5. Echo study reveals varying degrees of myocardial dysfunction, including an 
enlarged LA and /or LV, decreased contractility of the LV, and mitral regurgitation 
(MR). 
6. Laboratory studies may reveal mild reduction of Po2 and pH ( but usually without 
CO2 retention), hypoglycemia, and elevated CPK MB fraction in patients with 
significant TR. A myocardial perfusion scan may show a diffuse impairment of 
thallium-201 uptake (different from myocarditis, in which myocardial perfusion is 
normal). 
7. Infants with transient myocardial ischemia usually recover unless it is associated 
with severe acidosis, CNS damages, or advanced sepsis. 
d. Management 
1. Supportive measures with administration of oxygen, correction of acidosis, and 
treatment of hypogycemia are all that are required for mild cases. 
2. For severely affected infants, ventilatory assistance, short-acting inotropic agents ( 
such as dopamine), a vasodilator agent, and fluid restriction and diuretic(s) may be 
indicated. 
12. Emergency treatment if cyanotic CHD is suspected 
If a cyanotic CHD is suspected, PGE1 should be started or made available. The starting dose 
is 0.05 to 0.1 µg/kg/min, administered in a continuous IV drip. When the desired effects 
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(increased Po2, increased systemic blood pressure, and improved pH) are achieved, the dose 
should be reduced step-by-step to 0.01µg/kg/min. When there is no effect with the initial 
starting dose, it may be increased to 0.4 µg/kg/min.  
If echocardiography is not immediately available, the clinician caring for a newborn with 
possible cyanotic heart disease should not hesitate to start a prostaglandin infusion ( for a 
possible ductal-dependent lesion). Because of the risk of hypoventilation associated with 
prostaglandins, a practitioner skilled in neonatal endotracheal intubation must be available. 
Three common side effects of Prostaglandin E1 IV infusion are apnea (12%), fever (14%), 
and flushing (10%). 
13. Summary  
The evaluation of the cyanotic neonate should be done in an algorithmic manner that 
focuses on evaluation and management of the most life-threatening disease processes 
first.The hyperoxia test should be utilized early in the evaluation of these patients to assist in 
the differentiation and categorization of the cyanotic event. Be careful to obtain a detailed 
history of the prenatal, birth, and postnatal periods, as physicians will often be able to 
narrow the differential by the history alone. Neonates may decompensate very quickly, and 
preparations for a life-saving emergency should be made as soon as possible. 
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